The global viral conjunctivitis drugs market is anticipated to grow at a significant CAGR during the forecast period. The market is projected to show substantial growth owing to the high number of people suffering from viral conjunctivitis as well as eye-related allergies followed by the easier availability of the necessary treatment across the globe. Although the disease is very common, treatment for it is easily available globally. Generally, viral conjunctivitis is self diagnosable and there is the minimum need of undergoing any diagnostic test for it.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/viral-conjunctivitis-drugs-market
Emerging economies such as India also witnessed a high prevalence of the disease. According to an article published by the journal, Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. Hence, due to the high prevalence of the disease, the market is projected to have a steady growth during the forecast period. Furthermore, some key players operating in the market include AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Viral Conjunctivitis Drugs Market by Segment
By Drug Class
- Artificial tears
- Decongestants
- Anti-histamines
- NSAIDS
- Anti-Viral drugs
- Steroids
- Antibiotics
By Virus Type
- Adenovirus
- Enterovirus
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Viral Conjunctivitis Drugs Market is available at: https://www.omrglobal.com/industry-reports/viral-conjunctivitis-drugs-market
Viral Conjunctivitis Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie Inc.
- Takeda Pharmaceutical Co. Ltd.
- Bausch Health Co. Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
